Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. - Wikidata - wikimedia - TriplyDB

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography.

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography.

http://www.wikidata.org/entity/Q48370689

about

Speech-induced striatal dopamine release is left lateralized and coupled to functional striatal circuits in healthy humans: a combined PET, fMRI and DTI study A receptor-based model for dopamine-induced fMRI signal.Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach Modeling of PET data in CNS drug discovery and development.Modeling of receptor ligand data in PET and SPECT imaging: a review of major approaches.Extravasation into brain and subsequent spread beyond the ischemic core of a magnetic resonance contrast agent following a step-down infusion protocol in acute cerebral ischemia.PET Neurochemical Imaging Modes.A computerized infusion pump for control of tissue tracer concentration during positron emission tomography in vivo pharmacokinetic/pharmacodynamic measurements.Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.Ligand-receptor interactions as studied by PET: implications for drug development.Acute physical stress induces the alteration of the serotonin 1A receptor density in the hippocampus.Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.Dissociative changes in the Bmax and KD of dopamine D2/D3 receptors with aging observed in functional subdivisions of the striatum: a revisit with an improved data analysis method Dynamic functional imaging of brain glucose utilization using fPET-FDG.Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain.The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy.D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion Evaluation of the novel 5-HT4 receptor PET ligand [11C]SB207145 in the Göttingen minipig.Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.Intravenous ethanol increases dopamine release in the ventral striatum in humans: PET study using bolus-plus-infusion administration of [(11)C]raclopride.18F-Mefway PET imaging of serotonin 1A receptors in humans: a comparison with 18F-FCWAY Quantification of metabotropic glutamate subtype 5 receptors in the brain by an equilibrium method using 18F-SP203 Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome.Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351 Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380 Relative equilibrium plot improves graphical analysis and allows bias correction of standardized uptake value ratio in quantitative 11C-PiB PET studies.Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio.Measurement of Bmax and Kd with the glycine transporter 1 radiotracer ¹⁸F-MK6577 using a novel multi-infusion paradigm.Increased synaptic dopamine in the putamen in restless legs syndrome.Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation.Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.Quantification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion administration of 2-[18F]F-A85380.Feedback-controlled bolus plus infusion (FC-B/I) method for quantitative drug assessment in living brain with PET.

P2860

Q28707279-053E1E83-C6DD-483E-A2EC-56C14FFC3B7C Q30434854-D200FE70-B009-4F67-B12A-BEB723493C75 Q30512685-9E37E631-2158-47E2-B26D-87F2099B2DC9 Q30623699-74E81AAD-8E35-4996-B23D-65C4DD5BD7BC Q30632028-1040CB62-C1D1-4A9A-A33C-30FBE4745FBC Q30857036-540C10A5-70B9-4E6C-A530-F315087A7B82 Q31033080-083E4E95-5A3B-47F4-BED2-6DEE5328CB69 Q33338968-94399849-37AC-4834-8814-79AFED30F760 Q33786437-C890B9AA-334F-4F29-821D-A28BB4FFC911 Q33833648-F1E8EAB8-73D9-4169-A377-9824F29F9E5D Q33841668-096C664A-9D0E-44CF-A191-C5671CAE1B4D Q34040758-A281E9E8-84FC-42C7-A51B-7D5312E617DB Q34159762-CD0C8EC6-1CEB-4A49-9306-03A14F31AEB3 Q34220272-10A8ACF6-9D08-4F24-8BEA-178B049BE6FE Q34227983-165ACBCC-C3CD-4AD2-9EB5-853D9909EDD6 Q34425194-2CE7EDF3-40C3-4DA8-AB00-77ADAD36BCB9 Q34440136-A8EA90A4-E40D-48C6-A423-202EA9C5569A Q34661099-07452B08-2229-45E2-B2D2-D7BA906F3ADB Q34689059-5C08E727-4FD7-4FA2-9F71-DD72FB3885D8 Q34721945-DD7EA724-893C-4331-A78C-9C02CC7444CE Q34806210-05C327C1-3AC5-450D-9DA9-7E026149BF8C Q34829343-8F335F0B-E2F5-4BD3-BD94-8C8D727E6F86 Q35024059-079955CF-2E1F-40E9-A9DD-B478AEFF9841 Q35085729-AE256B65-1001-49A0-B362-89F0CD035F03 Q35143469-D18A2150-572B-41A3-A180-B1BDB213F72E Q35241015-00A5D12D-6B2D-4272-B92B-F7AEA26AF54B Q35663423-9A439431-928E-4F3E-B392-480075F9057E Q35950793-E15FB671-74D7-4B8F-94B0-B06424366A2D Q36050571-AF5A727D-362F-466A-A7BB-5C15B8C8CA03 Q36064072-9439A12E-72D3-4BE5-9B17-A2504DCD557E Q36066101-36579DC7-D926-4D03-8CA1-35B862A17716 Q36253478-7D74864E-0763-4B3E-A4DF-3C3555A67282 Q36267484-C7FA3FF9-A7F9-4E2D-9838-D9265B267357 Q36350490-71AA2CBA-8FBD-4B02-85DF-10446AB229F1 Q36473245-D4ABD677-964A-4061-8579-C5DDC0AF58F5 Q36492494-53A0FE1F-5454-4426-8C99-BE39421FC8A0 Q36535202-FE69B079-88C8-48A9-B46F-4F7B3873E669 Q36638627-10EF6AF0-C21F-4C5F-831E-FC6C0E85CDB4 Q36662874-ED3EE9B2-D84A-4808-8167-A65A56A669A5 Q36684186-20DF1FA5-4DC2-4B32-AA45-1894EB8C95CE

P2860

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography.

http://www.wikidata.org/entity/Q48370689

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh-hant

name

Comparison of bolus and infusi ...... positron emission tomography.

@en

Comparison of bolus and infusi ...... positron emission tomography.

@nl

type

label

Comparison of bolus and infusi ...... positron emission tomography.

@en

Comparison of bolus and infusi ...... positron emission tomography.

@nl

prefLabel

Comparison of bolus and infusi ...... positron emission tomography.

@en

Comparison of bolus and infusi ...... positron emission tomography.

@nl

P1433

Q48370689-74AA5567-913C-4E21-B7F7-A41F0500EAA6

P1476

Q48370689-A7EF9DC9-011E-4844-ACB8-4E8C18FF92EA

P2093

Q48370689-1E846B69-F74E-44EA-BF3E-18C64A44C8DF

Q48370689-64C61952-8F17-4871-8723-6BE4A6BE44D4

Q48370689-73D68229-1EEE-4FBD-A0F6-56F06BAC17C6

Q48370689-75D5328F-7CD2-4D41-B7C2-C169BE5D06F5

Q48370689-A0B4AA4C-1CB9-48B8-833E-E40833CCB797

Q48370689-ADEAF3FC-2A84-4F7D-A8EF-B395142243B7

Q48370689-C834DE2F-DE4C-4A2C-BC07-FC61F22413BC

P2860

Q48370689-0CA9157F-5198-4831-AA64-F76961B4137B

Q48370689-0D3B2D68-9E3E-42C5-BA0A-786E49D3BE1D

Q48370689-25A7B56C-2FCB-4429-B5DA-1A91FAADC468

Q48370689-2C379626-AF3F-4B07-87CB-A1431973C469

Q48370689-3FC117DD-7BCC-4FED-BDA0-3423DB3406CE

Q48370689-561098F3-EEB5-4BAC-92C1-67FFC7CD0E9A

Q48370689-57918BCC-ECD2-46A6-A375-F84992728DB2

Q48370689-586C5C1F-2969-4686-AA49-22DBB800C119

Q48370689-5B9FF22A-4480-48F3-8656-EA1FDA276B05

Q48370689-63723C38-2EF8-484B-9C2A-35A702B132AC

P304

Q48370689-D0BA9B64-9B5E-431A-B9F3-C726D9C20AB9

P31

Q48370689-59D2D246-9DC5-4C69-80ED-02C46DAB52F5

P356

Q48370689-AE8888B6-D7F4-463C-974A-BDDB729EB8CE

P433

Q48370689-6D75ED84-B183-4425-AF88-D9916812F1A6

P478

Q48370689-838976C9-0BE5-473D-8213-B9DB0360C847

P577

Q48370689-4EA6A8A8-5F2E-4973-AD74-9DA499749F07

P5875

Q48370689-E4886614-A6C9-4A44-9BD5-3AE6189AF636

P698

Q48370689-AC47C206-9C79-4967-BD17-3CCAF9AE2493

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Comparison of bolus and infusi ...... positron emission tomography.

@en

P2093

Blasberg RG

http://www.w3.org/2001/XMLSchema#string

Carson RE

http://www.w3.org/2001/XMLSchema#string

Channing MA

http://www.w3.org/2001/XMLSchema#string

Cohen RM

http://www.w3.org/2001/XMLSchema#string

Dunn BB

http://www.w3.org/2001/XMLSchema#string

Herscovitch P

http://www.w3.org/2001/XMLSchema#string

Rice KC

http://www.w3.org/2001/XMLSchema#string

P2860

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

Methods for Quantifying the transport of drugs across brain barrier systems.

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.

Precision and accuracy considerations of physiological quantitation in PET.

Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands.

3-[18F]Acetylcyclofoxy: a useful probe for the visualization of opiate receptors in living animals.

Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studies.

A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro.

P304

24-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.1993.6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

1993-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14819485

http://www.w3.org/2001/XMLSchema#string

P698

8380178

http://www.w3.org/2001/XMLSchema#string